GB2486713B - Pharmaceutical composition for treating urinary system disorders - Google Patents

Pharmaceutical composition for treating urinary system disorders

Info

Publication number
GB2486713B
GB2486713B GB1021879.0A GB201021879A GB2486713B GB 2486713 B GB2486713 B GB 2486713B GB 201021879 A GB201021879 A GB 201021879A GB 2486713 B GB2486713 B GB 2486713B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
system disorders
urinary system
treating urinary
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1021879.0A
Other versions
GB2486713A (en
GB201021879D0 (en
Inventor
Ke Tse-Hao
Chen Chien-Li
Hung Ming-Chien
Yuan Hsiao-Yun
Chang Shih-Yi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Feng Chia University
Original Assignee
Feng Chia University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Feng Chia University filed Critical Feng Chia University
Priority to GB1021879.0A priority Critical patent/GB2486713B/en
Publication of GB201021879D0 publication Critical patent/GB201021879D0/en
Publication of GB2486713A publication Critical patent/GB2486713A/en
Application granted granted Critical
Publication of GB2486713B publication Critical patent/GB2486713B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
GB1021879.0A 2010-12-23 2010-12-23 Pharmaceutical composition for treating urinary system disorders Active GB2486713B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1021879.0A GB2486713B (en) 2010-12-23 2010-12-23 Pharmaceutical composition for treating urinary system disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1021879.0A GB2486713B (en) 2010-12-23 2010-12-23 Pharmaceutical composition for treating urinary system disorders

Publications (3)

Publication Number Publication Date
GB201021879D0 GB201021879D0 (en) 2011-02-02
GB2486713A GB2486713A (en) 2012-06-27
GB2486713B true GB2486713B (en) 2016-06-29

Family

ID=43598920

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1021879.0A Active GB2486713B (en) 2010-12-23 2010-12-23 Pharmaceutical composition for treating urinary system disorders

Country Status (1)

Country Link
GB (1) GB2486713B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102385760B1 (en) * 2019-04-26 2022-04-11 티씨엠 바이오테크 인터내셔널 코포레이션 Pharmaceutical composition for the prevention of recurrent urinary tract infection

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277392B1 (en) * 1999-09-16 2001-08-21 Carbon Medical Technologies, Inc. Tissue injectable composition
US20050220829A1 (en) * 2004-03-30 2005-10-06 Chien-Min Sung Healthcare and cosmetic compositions containing nanodiamond
EP1609475A1 (en) * 2003-04-03 2005-12-28 Kureha Chemical Industry Co., Ltd. Remedy or preventive for low turnover bone diseases
WO2008021378A1 (en) * 2006-08-17 2008-02-21 Ocera Therapeutics, Inc. Use of adsborbent carbon microspheres to treat intestinal bacterial infections
US20100190866A1 (en) * 2009-01-23 2010-07-29 Kobo Products, Inc. Advanced antimicrobial carbon black dispersion

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277392B1 (en) * 1999-09-16 2001-08-21 Carbon Medical Technologies, Inc. Tissue injectable composition
EP1609475A1 (en) * 2003-04-03 2005-12-28 Kureha Chemical Industry Co., Ltd. Remedy or preventive for low turnover bone diseases
US20050220829A1 (en) * 2004-03-30 2005-10-06 Chien-Min Sung Healthcare and cosmetic compositions containing nanodiamond
WO2008021378A1 (en) * 2006-08-17 2008-02-21 Ocera Therapeutics, Inc. Use of adsborbent carbon microspheres to treat intestinal bacterial infections
US20100190866A1 (en) * 2009-01-23 2010-07-29 Kobo Products, Inc. Advanced antimicrobial carbon black dispersion

Also Published As

Publication number Publication date
GB2486713A (en) 2012-06-27
GB201021879D0 (en) 2011-02-02

Similar Documents

Publication Publication Date Title
IL225597A0 (en) Pharmaceutical composition, methods for treating and uses thereof
EP2558115A4 (en) Methods for treating metabolic disorders using fgf
HK1170490A1 (en) Pharmaceutical composition for treating or preventing glaucoma
EP2611765A4 (en) Methods for treating neurodegenerative diseases
EP2621498A4 (en) Combination treatment for dermatological conditions
EP2523660A4 (en) Solid-forming local anesthetic formulations for pain control
IL223078A (en) Composition for treating methotrexate-resistant disorders comprising 10-propargyl-10 -deazaaminopterin
EP2550361A4 (en) Compositions and methods for treating neurological disorders
EP2688402A4 (en) Methods for treating or preventing urological inflammation
EP2558103A4 (en) Pharmaceutical composition for treating macular edema
EP2465512A4 (en) Pharmaceutical composition for suppressing pain
IL221415A0 (en) Compounds useful for treating neurodegenerative disorders
GB201010359D0 (en) Compounds for treating proliferative disorders
EP2614821A4 (en) Pharmaceutical composition for treating anxiety disorder, containing n-acetyl-l-cysteine or derivative thereof
HK1183807A1 (en) Composition for treating neurodegenerative disease or neuropathological condition
PL2604264T3 (en) Pharmaceutical composition for treating viral diseases
HUE047320T2 (en) Composition for the treatment of infertility
PL2562160T3 (en) Therapeutic agent or preventive agent for urine collection disorder
ZA201201894B (en) Pharmaceutical combination for treating tumor
ZA201204341B (en) Pharmaceutical composition for treating gutaneous burns
GB2486713B (en) Pharmaceutical composition for treating urinary system disorders
EP2578206A4 (en) Pharmaceutical composition for the treatment of disorders of the lower section of the urogenital system
PL2663318T3 (en) Pharmaceutical composition for treating cancer
EP2548580A4 (en) Pharmaceutical for pseudo-exercise therapy
EP2785343A4 (en) Pharmaceutical composition for preventing or treating hyperlipidemia